Tarbox Family Office, Inc. Amgen Inc Transaction History

Tarbox Family Office, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $51,909 - $57,766	-225 Closed	0 $0
Q1 2022 Apr 25, 2022	SELL	$219.27 - $242.57 $349,954 - $387,141	-1,596 Reduced 87.64%	225 $54,000
Q4 2021 Jan 06, 2022	SELL	$198.88 - $227.6 $3,778 - $4,324	-19 Reduced 1.03%	1,821 $410,000
Q4 2020 Jan 27, 2021	SELL	$216.38 - $257.67 $2,380 - $2,834	-11 Reduced 0.59%	1,840 $423,000
Q3 2020 Oct 22, 2020	SELL	$234.65 - $260.95 $2,111 - $2,348	-9 Reduced 0.48%	1,851 $470,000
Q1 2020 Apr 30, 2020	SELL	$182.24 - $241.7 $178,048 - $236,140	-977 Reduced 34.44%	1,860 $377,000
Q4 2019 Jan 31, 2020	BUY	$189.21 - $243.2 $281,166 - $361,395	1,486 Added 109.99%	2,837 $684,000
Q2 2019 Aug 02, 2019	BUY	$166.7 - $195.41 $1,000 - $1,172	6 Added 0.45%	1,351 $249,000
Q4 2018 Feb 01, 2019	BUY	$178.4 - $208.25 $713 - $833	4 Added 0.3%	1,345 $262,000
Q1 2018 Apr 25, 2018	SELL	$169.43 - $198.0 $42,865 - $50,094	-253 Reduced 15.87%	1,341 $229,000
Q4 2017 Jan 29, 2018	BUY	$168.79 - $188.59 $42,028 - $46,958	249 Added 18.51%	1,594 $277,000
Q3 2017 Oct 19, 2017	BUY	$167.29 - $191.0 $225,005 - $256,895	1,345	1,345 $251,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.